Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS): Kindred disorders of autonomic regulation

Debra E. Weese-Mayer, Elizabeth M. Berry-Kravis, Isabella Ceccherini, Casey M. Rand

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS) were long considered rare disorders of respiratory control and more recently have been highlighted as part of a growing spectrum of disorders within the rubric of autonomic nervous system (ANS) dysregulation (ANSD). CCHS typically presents in the newborn period with a phenotype including alveolar hypoventilation, symptoms of ANSD and, in a subset of cases, Hirschsprung disease and later tumors of neural crest origin. Study of genes related to autonomic dysregulation and the embryologic origin of the neural crest led to the discovery of PHOX2B as the disease-defining gene for CCHS. Like CCHS, SIDS is thought to result from central deficits in control of breathing and ANSD, although SIDS risk is most likely defined by complex multifactorial genetic and environmental interactions. Some early genetic and neuropathological evidence is emerging to implicate serotonin systems in SIDS risk. The purpose of this article is to review the current understanding of the genetic basis for CCHS and SIDS, and discuss the impact of this information on clinical practice and future research directions.

Original languageEnglish
Pages (from-to)38-48
Number of pages11
JournalRespiratory Physiology and Neurobiology
Volume164
Issue number1-2
DOIs
Publication statusPublished - Dec 10 2008

Fingerprint

Sudden Infant Death
Hypoventilation
Hirschsprung Disease
Neural Crest
Autonomic Nervous System
Genes
Serotonin
Respiration
Congenital central hypoventilation syndrome
Phenotype

Keywords

  • 5-HTT
  • ANS dysregulation
  • CCHS
  • FEV
  • PHOX2B
  • SIDS
  • SLC6A4

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Neuroscience(all)

Cite this

Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS) : Kindred disorders of autonomic regulation. / Weese-Mayer, Debra E.; Berry-Kravis, Elizabeth M.; Ceccherini, Isabella; Rand, Casey M.

In: Respiratory Physiology and Neurobiology, Vol. 164, No. 1-2, 10.12.2008, p. 38-48.

Research output: Contribution to journalArticle

@article{87f8a7e4f27e4f6cb6317c6f247ba85c,
title = "Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS): Kindred disorders of autonomic regulation",
abstract = "Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS) were long considered rare disorders of respiratory control and more recently have been highlighted as part of a growing spectrum of disorders within the rubric of autonomic nervous system (ANS) dysregulation (ANSD). CCHS typically presents in the newborn period with a phenotype including alveolar hypoventilation, symptoms of ANSD and, in a subset of cases, Hirschsprung disease and later tumors of neural crest origin. Study of genes related to autonomic dysregulation and the embryologic origin of the neural crest led to the discovery of PHOX2B as the disease-defining gene for CCHS. Like CCHS, SIDS is thought to result from central deficits in control of breathing and ANSD, although SIDS risk is most likely defined by complex multifactorial genetic and environmental interactions. Some early genetic and neuropathological evidence is emerging to implicate serotonin systems in SIDS risk. The purpose of this article is to review the current understanding of the genetic basis for CCHS and SIDS, and discuss the impact of this information on clinical practice and future research directions.",
keywords = "5-HTT, ANS dysregulation, CCHS, FEV, PHOX2B, SIDS, SLC6A4",
author = "Weese-Mayer, {Debra E.} and Berry-Kravis, {Elizabeth M.} and Isabella Ceccherini and Rand, {Casey M.}",
year = "2008",
month = "12",
day = "10",
doi = "10.1016/j.resp.2008.05.011",
language = "English",
volume = "164",
pages = "38--48",
journal = "Respiratory Physiology and Neurobiology",
issn = "1569-9048",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS)

T2 - Kindred disorders of autonomic regulation

AU - Weese-Mayer, Debra E.

AU - Berry-Kravis, Elizabeth M.

AU - Ceccherini, Isabella

AU - Rand, Casey M.

PY - 2008/12/10

Y1 - 2008/12/10

N2 - Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS) were long considered rare disorders of respiratory control and more recently have been highlighted as part of a growing spectrum of disorders within the rubric of autonomic nervous system (ANS) dysregulation (ANSD). CCHS typically presents in the newborn period with a phenotype including alveolar hypoventilation, symptoms of ANSD and, in a subset of cases, Hirschsprung disease and later tumors of neural crest origin. Study of genes related to autonomic dysregulation and the embryologic origin of the neural crest led to the discovery of PHOX2B as the disease-defining gene for CCHS. Like CCHS, SIDS is thought to result from central deficits in control of breathing and ANSD, although SIDS risk is most likely defined by complex multifactorial genetic and environmental interactions. Some early genetic and neuropathological evidence is emerging to implicate serotonin systems in SIDS risk. The purpose of this article is to review the current understanding of the genetic basis for CCHS and SIDS, and discuss the impact of this information on clinical practice and future research directions.

AB - Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS) were long considered rare disorders of respiratory control and more recently have been highlighted as part of a growing spectrum of disorders within the rubric of autonomic nervous system (ANS) dysregulation (ANSD). CCHS typically presents in the newborn period with a phenotype including alveolar hypoventilation, symptoms of ANSD and, in a subset of cases, Hirschsprung disease and later tumors of neural crest origin. Study of genes related to autonomic dysregulation and the embryologic origin of the neural crest led to the discovery of PHOX2B as the disease-defining gene for CCHS. Like CCHS, SIDS is thought to result from central deficits in control of breathing and ANSD, although SIDS risk is most likely defined by complex multifactorial genetic and environmental interactions. Some early genetic and neuropathological evidence is emerging to implicate serotonin systems in SIDS risk. The purpose of this article is to review the current understanding of the genetic basis for CCHS and SIDS, and discuss the impact of this information on clinical practice and future research directions.

KW - 5-HTT

KW - ANS dysregulation

KW - CCHS

KW - FEV

KW - PHOX2B

KW - SIDS

KW - SLC6A4

UR - http://www.scopus.com/inward/record.url?scp=53849113295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849113295&partnerID=8YFLogxK

U2 - 10.1016/j.resp.2008.05.011

DO - 10.1016/j.resp.2008.05.011

M3 - Article

C2 - 18579454

AN - SCOPUS:53849113295

VL - 164

SP - 38

EP - 48

JO - Respiratory Physiology and Neurobiology

JF - Respiratory Physiology and Neurobiology

SN - 1569-9048

IS - 1-2

ER -